Global Technetium-99m Market Size, Share, Forecast Report, 2020-2027

The global Technetium-99m market garnered revenue around USD 2.9 Billion in 2019 and projected to reach USD 3.9 Billion in 2027, with at a compound annual growth rate (CAGR) 3.4% throughout the estimate period from 2020 to 2027. Some of the factors driving the Technetium-99m market are expansion activities of key radiopharma players; applications in clinical trials; and increase in aging population; pipeline assessment of new drugs; and disease indication mortality. Shutdown of some of the nuclear reactors has led to the development of Technetium-99m generator as an alternate source of production of radioisotopes. Increase in the number of diagnostic procedures conducted using Technetium-99m based modality for various diseases is likely to further drive the uptake of Technetium-99m. Ongoing advances in SPECT/CT are diverse. For instance, whole-body SPECT/CT imaging in which series of images are acquired from multiple bed positions, similar to PET/CT, is gaining traction.  Technetium-99m has been successful in treating persistent diseases with low toxic side effects. This has increased global Technetium-99m production for usage in medical imaging and nuclear medicine.

According to the World Nuclear Association, over 10,011 hospitals across the world use radioisotopes in medicine and 90% of the procedures are used for diagnosis of infectious diseases, cancer, and neurological disorders. Based on end user, the hospital segments accounted for major share of the global Technetium-99m market in terms of revenue in 2019. The segment is expected to expand at a moderate CAGR during the forecast period. Hospitals are major end users of Technetium-99m products, which are used in the treatment of diseases such as cardiovascular heart diseases, neurological disorders, and diabetes. Hospitals are an important channel for the usage of radioisotopes as nuclear medicine.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Technetium-99m market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Technetium-99m market growth.

The global Technetium-99m market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

Leading players in the global Technetium-99m market include GE Healthcare, Curium, Lantheus Medical Imaging, Inc., Mallinckrodt, Siemens Healthineers, Advanced Accelerator Applications, Bayer AG, Eckert & Ziegler, Advanced Cyclotron Systems, Inc., Sumitomo Heavy Industries, Ltd., Philips, and Jubilant Life Sciences Limited.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Technetium-99m Market: Segmentation

Technetium-99m Market, by Isotopic Application

• Gamma Camera
• Single Photon Emission Computed Tomography (SPECT)

Technetium-99m Market, by End User

• Hospitals
• Diagnostic Centers
• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA